1. Home
  2. KELYA vs CCCC Comparison

KELYA vs CCCC Comparison

Compare KELYA & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$15.36

Market Cap

340.1M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.74

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
CCCC
Founded
1946
2015
Country
United States
United States
Employees
4900
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.1M
404.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KELYA
CCCC
Price
$15.36
$3.74
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$15.00
$12.20
AVG Volume (30 Days)
405.7K
4.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$7.98
$1.69
52 Week High
$15.52
$5.17

Technical Indicators

Market Signals
Indicator
KELYA
CCCC
Relative Strength Index (RSI) 78.02 43.11
Support Level $8.30 $2.10
Resistance Level N/A $3.89
Average True Range (ATR) 0.52 0.37
MACD 0.20 -0.10
Stochastic Oscillator 86.37 16.47

Price Performance

Historical Comparison
KELYA
CCCC

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: